Healthcare >> Analyst Interviews >> January 17, 2000

Outlook For Biotechnology : Richard A. Van Den Broek – Chase H&q

RICHARD A. VAN DEN BROEK is a Managing Director of Research with Hambrecht & Quist. Prior to joining the firm in 1996, he was associated with Oppenheimer & Company as a Vice President and Equity Analyst covering the biotechnology industry. From 1988 to 1991, he researched viruses under the auspices of Dr. Bernard Fields, the Chairman of the Microbiology and Molecular Genetics department at Harvard Medical School. A Chartered Financial Analyst, Mr. van den Broek holds a Bachelor's degree from Harvard University. Profile
TWST: Tell us how the approach that Hambrecht & Quist takes to

biotechnology differs from that taken by your competitors.

Mr. van den Broek: Most of our traditional competitors have gone